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knees than meniscectomy only controls through 5 years. The additional
tissue regeneration supported by the CMI may decrease progression of
degenerative changes and reduce the necessity and frequency for addi-
tional surgeries. This study further conﬁrms the importance of preserving
as much meniscus tissue as possible at the time of meniscus surgery,
and clearly it supports the potential positive beneﬁts of regrowing or
regenerating lost meniscus tissue. Our hypothesis was afﬁrmed.
462 SIX-YEAR RESULTS WITH COLLAGEN MENISCUS
IMPLANTS (CMI) WITH EMPHASIS ON LOCATION AND
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Purpose: Prospectively, we determined amount of meniscus loss and
anatomic location of Collagen Meniscus Implant (CMI) placement after
partial medial meniscectomy, then at 1-year relook we determined total
meniscus tissue present based on surface area coverage. We correlated
percent of meniscus and anatomic location of the original lesion with func-
tion and activity levels six years after CMI placement. We hypothesized
that meniscus amount and anatomic location would inﬂuence clinical
function and activity levels.
Methods: In a prospective randomized controlled multicenter clinical
trial (Level of Evidence I), 114 chronic patients (1 to 3 prior partial
meniscectomies on the involved meniscus) 18 to 60 years old underwent
partial medial meniscectomy, and then randomly one group received a
CMI to ﬁll the meniscus defect. There were 68 meniscectomy only controls
and 46 CMI patients. At index surgery, amount and anatomic location of
meniscus removed and CMI placement were documented on a standard
grid (Figure). Locations were categorized as posterior (A), middle (B),
or anterior (C) third. A 1-year relook was done on CMI patients, and
meniscus surface area coverage was measured. Patients were followed
clinically for a minimum of two years and subjectively annually thereafter.
Average follow-up was 69 months (range, 24 to 92). All patients completed
validated questionnaires including Lysholm and Tegner scores to assess
function and activity.
Results: For CMI patients, 29 had lesions which included the posterior
and middle thirds (AB), and 17 had lesions involving all three zones
(ABC). Lysholm scores were signiﬁcantly higher in patients with AB
lesions (81) compared to ABC lesions (71), p = 0.046. AB lesion patients
also had signiﬁcantly higher Tegner index (0.70) than ABC lesion patients
(0.22), thus the AB patients regained more of their lost activity, p = 0.049.
Comparing all patients with 60% meniscus surface area coverage, CMI
patients had signiﬁcantly higher Tegner index compared to controls (0.59
vs. 0.30), p = 0.036. No differences between treatment groups were seen
in patients with <60% meniscus surface area coverage. When comparing
24 month values to those at ﬁnal follow-up, controls had no change for
Lysholm (p = 0.13) or Tegner (p = 0.39) scores, but CMI patients improved
signiﬁcantly over time for both Lysholm (p = 0.02) and Tegner (p = 0.04)
scores.
Conclusions: The zone of meniscus involvement inﬂuenced clinical
outcomes at 6 years in CMI patients with those whose lesions extended
into all three zones doing worse than those with lesions in posterior
and middle zones only. Patients with successful CMI procedures yielding
60% meniscus surface area coverage were signiﬁcantly better than
meniscectomy only controls for both clinical function and activity levels.
Noteworthy, CMI patients continue to improve over time for clinical func-
tion and activity levels, but control patients do not.
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Purpose: Degeneration and tearing of rotator cuff tendon causes sig-
niﬁcant morbidity in our ageing population. Treatment options for cuff
disorders are limited by a lack of information concerning the fundamental
mechanisms that cause tendinopathy. Pre- and post-rupture changes
are difﬁcult to study in humans. An animal model of shoulder tendon
injury has been recently established in our laboratories, whereby the
pathological effects of both overstress (OS) and stress deprivation (SD)
on tendons can be evaluated and potential molecular mechanism studied
simultaneously.
Methods: Twenty-four 2 year-old Merino wethers had the infraspinatus
tendon of one forelimb partially transected; 24 sheep had tendons ex-
posed but not cut (sham) and 24 sheep were non-operated controls
(NOC). After sacriﬁce of 6 animals in each group at 2, 13, 26 and
52 weeks, 2 regions of tensile tendon (deﬁned by ﬁnite element analysis to
be SD or OS following the transection) were removed from each shoulder.
Tendon was formalin-ﬁxed and processed for histology or snap frozen
for subsequent total RNA extraction and real time RT-PCR using vali-
dated ovine-speciﬁc primers. Genes examined were aggrecan, versican,
decorin, lumican, ﬁbromodulin, biglycan, MMP-13 and ADAMTS-1, -4 and
-5.
Results: Two weeks after transection, signiﬁcant pathological changes
were apparent in both SD and OS tensile tendon when compared with
either NOC or sham-operated tendons (all p< 0.05). By 26 and 52 weeks,
histopathology scores, including collagen alignment, had returned to
sham levels in OS but not SD tensile tendon. Regardless of transection-
induced OS or SD, proteoglycan staining in both regions signiﬁcantly
increased and was still elevated at 52 weeks (p< 0.02), by which time
deﬁned areas of chondroid metaplasia had become evident.
There was no difference in gene expression between sham and NOC.
In SD tendon, expression ratios (fold change transected from sham) of
versican, biglycan and lumican were signiﬁcantly increased (all p< 0.05)
and decorin and ﬁbromodulin decreased (p< 0.005) at multiple time
points. In OS tendons, upregulated expression of aggrecan and biglycan
only became evident at 13 weeks post-transection (both p< 0.02), and
decorin, ﬁbromodulin and lumican were not regulated. MMP-13 (a major
ﬁbrillar collagenase) was signiﬁcantly upregulated in SD (p< 0.005) but
not OS tendon. Expression of all three ADAMTS, which would normally
be implicated in aggrecan and versican proteolysis, was not signiﬁcantly
changed in either SD or OS tendon at any timepoint in this study.
Conclusions: Proteoglycan accumulation and chondroid metaplasia are
major pathological ﬁndings in both SD and OS tensile tendon but the
underlying molecular mechanisms appear to be temporally different. Ex-
cess proteoglycan may alter tendon biomechanics, increase susceptibility
to tearing and inhibit repair processes. Pathological accumulation of
proteoglycan, especially aggrecan and versican, in tensile tendon may
be associated with lack of ADAMTS activity. This has implications for
the treatment of tendinopathy, where molecular therapies that decrease
aggrecan and increase ADAMTS may be beneﬁcial. Furthermore, these
results suggest that therapies aimed at decreasing ADAMTS activity in
the joint to treat osteoarthritis may induce unwanted side effects in joint
(and possibly other) tendons in the longterm.
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Purpose: Tendon injury leads to a local inﬂammatory response, charac-
terized by the induction of pro-inﬂammatory cytokines such as interleukin
(IL)-1beta and tumor necrosis factor (TNF)-alpha. Tendon healing is a
time consuming process and strongly inﬂuenced by this post-traumatic
inﬂammation. More and more evidence arose that the immunoregulatory
Th2 cytokines Il-6 and Il-10 might also contribute to the complex remod-
elling processes observed during wound healing in connective tissues.
Since the role and interplay of pro-inﬂammatory and immunoregulatory
cytokines in tendon remains still unclear, the aim of the present study was
to analyze the effects of TNF-alpha, Il-6 and Il-10 on key parameters of
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tendon homeostasis such as expression of important extracellular matrix
components (collagen type I, elastin), matrix degrading enzymes (MMP-1,
-3) and to evaluate tenocyte inﬂammatory response by investigation
of pro-inﬂammatory (TNF-alpha, Il-1beta) and immunoregulatory (Il-6)
cytokine as well as suppressors of cytokine signalling (SOCS1, SOCS3)
expression.
Methods: Cultured primary human tenocytes were investigated for en-
dogen Il-10 and Il-10 receptor-1 (Il-10R1) expression as a prerequisite
for Il-10 signalling using RTD PCR and immunohistichemistry. Serum
starved tenocytes were treated with recombinant human Il-6, Il-10, TNF-
alpha or combinations of TNF-alpha with Il-6 and Il-10 (10 or 50 ng/mL,
24 h, 48 h). Expression of type I collagen, elastin, MMP-1, -3, TNF-
alpha, Il-1beta, Il-6, SOCS1 and SOCS3 was studied by RTD PCR,
immunohistochemistry or by western blot analysis.
Results: In the presence of TNF-alpha human tenocytes expressed
Il-10 and the Il-10 speciﬁc Il-10R1. Il-6 stimulated tenocyte collagen
type I expression at the protein level, but had obviously no effect on
elastin expression. TNF-alpha ampliﬁed slightly elastin expression, but
decreased type I collagen deposition.
TNF-alpha activated the tenocytes to highly up-regulate their gene
expression for matrix degrading enzymes (MMP-1, -3) as well as
pro-inﬂammatory (TNF-alpha, Il-1beta) and immunoregulatory cytokines
(Il-6). The treatment of tenocytes with recombinant Il-6 and Il-10 alone had
no major effect on their cytokine expression, the co-treatment with Il-6 or
Il-10 and TNF-alpha inhibited only slightly the expression of TNF-alpha,
Il-1beta and Il-6 in response to TNF-alpha. TNF-alpha stimulation, but
not the treatment with Il-6 or Il-10 augmented SOCS1, whereas SOCS3
gene expression was only up-regulated by Il-6 in tenocytes.
Conclusions: Tenocytes are able to express the immunoregulatory cy-
tokine Il-10 and its speciﬁc Il-10R1. However, the function of Il-10 in
tendon remains mainly unclear: Il-10 might play a role under inﬂammatory
conditions in tendon.
The results of the study indicate inﬂammatory, catabolic, but also distinct
anabolic effects of TNF-alpha which strongly activates the tenocytes
to produce several pro-inﬂammatory and immunoregulatory cytokines,
matrix degrading enzymes, suppresses collagen type I deposition but,
however, increases elastin expression. The observed induction of SOCS1
by TNF-alpha was not sufﬁcient to inhibit the TNF-alpha up-regulation
mediated by TNF-alpha. The multiple roles of TNF-alpha in tendon remod-
elling and the modulatory inﬂuence of Il-6 and Il-10 under inﬂammatory
conditions have to be further analysed.
Pain: Clinical
465 MODERATE TO SEVERE OSTEOARTHRITIS, BUT NO PAIN
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Purpose: It is known that there is discordance between pathological
evidence of osteoarthritis (OA), seen with radiographs, and clinical symp-
toms and signs. Suggestions are made that this is particularly true for the
less severe grades of OA and that in more severe grades of OA pain is
more common. Still there are people with Kellgren and Lawrence (K&L)
grade 3 or 4 of OA in hip and knee that do not have pain in hip or knee. To
better understand the absence of pain in people with moderate or severe
OA, it is necessary to ﬁnd out determinants related to pain in people with
moderate to severe radiological OA. In this study, we determine which
determinants explain the pain in hip or knee in people with Kellgren and
Lawrence grade 3 or 4 in knee or hip.
Methods: Participants in this study were participants of the Rotterdam
study, which included from 1990 onwards all inhabitants of 55 years
and older living in Ommoord, a district in Rotterdam. The aim of the
Rotterdam study was to investigate determinants of disease occurrence
and progression of chronic disabling diseases. All participants have had
an interview, an examination and x-rays.
We identiﬁed all participants who hade moderate to severe OA (K&L
grade 3 or 4) in hip or knee. Univariate logistic regression was used
to analyze the association between pain and moderate to severe OA of
knee or hip. Patient characteristics and variables for co-morbidity, health
status, depression, widespread pain, other symptoms of osteoarthritis,
familial OA, and bilaterality were tested.
Results: There were 7983 men and women participating in the Rotterdam
Study, of which 6450 visited the research centre for baseline examination.
Of 3035 participants the x-ray of the knees and 3320 x-rays of the hips
were scored with K&L. We identiﬁed 164 participants with moderate to
severe OA (K&L grade 3 or 4), 99 participants had pain in knee or hip and
65 participants had no pain in knee or hip. In univeriate logistic regression
analysis pain in knee or hip is associated with morning stiffness (OR 3.9,
p = 0.000), bilateral knee OA grade 3 or 4 (OR=3.0, p = 0.038), health
complaint (OR=3.0, p = 0.001).
Conclusions: Morning stiffness, bilateral knee OA, and health complains
are indicators for having pain with moderate to severe OA. These deter-
minants are all indicators of disease and cannot explain the absence of
pain with moderate to severe OA. Maybe an explanation for the absence
in pain can be found in genetic research. Another limitation of this study
is that a lot of possible determinants are not measured in this cohort, for
example physical activity. The sample size of this study was very small
and there were only 65 cases.
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Purpose: To establish an objective and accurate quantiﬁcation method of
the structural severity of knee osteoarthritis (OA), we have developed a
computer program KOACAD (knee OA computer-aided diagnosis) which
for the ﬁrst time has realized a fully automatic measurement of major OA
parameters on plain knee radiographs (OA&C 2008). The present study
sought to identify radiographic factors that predict the future progression
of pain in knee OA patients by applying the KOACAD system to the NIH
Osteoarthritis Initiative (OAI) public data.
Methods: This study used the progression subcohort data in the OAI
(public-use dataset 0.C.1), since all subjects in the subcohort were knee
OA patients with frequent knee symptoms and radiographic knee OA.
From 814 subjects, 722 without knee surgery (292 men and 430 women,
average 61.8 yrs.) who completed the WOMAC scores at baseline and
24-month follow-up surveys were enrolled. More than 20% increase of
the WOMAC knee pain score during the follow-up period was deﬁned
as the progression of knee pain. On plain anteroposterior radiographs
at the baseline, we measured the six major OA parameters: medial and
lateral joint space area (JSA), medial and lateral minimum joint space
width (mJSW), osteophyte area, and tibiofemoral angle (TFA), using
the KOACAD system. The non-paired t-test was used to examine the
difference of age, gender, body mass index (BMI), and the KOACAD
parameters between the groups with and without the knee pain progres-
sion. Furthermore, odds ratio (OR) and the associated 95% conﬁdence
interval (CI) were determined using logistic regression analysis after
adjustment for age, gender and BMI. A p-value of <0.05 for analysis
of safety variables was considered signiﬁcant.
Results: The mean WOMAC pain score was 4.1 (range: 0−19) at
the baseline and 3.8 (0−18) at the 24-month follow-up, and the mean
change was −0.3 (−13±10). In the overall 722 patients, 46 (14 men
and 32 women) showed the knee pain progression. There was no
signiﬁcant difference of age, gender, and BMI between the groups with
and without the pain progression (46 vs. 676). Among the KOACAD
parameters at the baseline, medial JSA (93.6±5.7 for progression vs.
92.3±1.4mm2 for non-progression; mean±S.D.), lateral JSA (102.8±6.8
vs. 113.5±1.7mm2), medial mJSW (2.6±0.2 vs. 2.8±0.1mm), os-
teophyte area (1.1±1.0 vs. 2.7±0.2mm2), and TFA (176.3±0.2 vs.
176.5±0.6 degree) were not signiﬁcantly different between the two
groups; however, lateral mJSW (3.3±0.5 vs. 4.3±0.1mm) was signiﬁ-
cantly lower in the group with the knee pain progression (p = 0.0083).
Logistic regression analysis after adjustment for age, gender and BMI
conﬁrmed that low lateral mJSWwas associated with the pain progression
(OR=1.24, 95%CI = 1.04−1.46). The association was stronger in women
(OR=1.32, 95%CI = 1.05−1.68) than in men (OR=1.13, 95%CI =
0.94−1.41).
Conclusions: Utilizing the KOACAD system and the OAI public data, we
have found that lateral joint space narrowing on plain radiographs, but not
medial joint space narrowing, osteophytosis or knee angulation, can be a
predictive parameter of the pain progression in knee OA patients. Inter-
estingly, our previous cross-sectional study using the KOACAD showed
signiﬁcant association of medial joint space narrowing, but not lateral joint
space narrowing, with the presence of knee pain in a normal population-
based cohort, implicating a distinct etiology between the incidence and
